↓ Skip to main content

Greater Celandine's Ups and Downs−21 Centuries of Medicinal Uses of Chelidonium majus From the Viewpoint of Today's Pharmacology

Overview of attention for article published in Frontiers in Pharmacology, April 2018
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (62nd percentile)
  • Good Attention Score compared to outputs of the same age and source (77th percentile)

Mentioned by

twitter
5 X users

Citations

dimensions_citation
80 Dimensions

Readers on

mendeley
108 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Greater Celandine's Ups and Downs−21 Centuries of Medicinal Uses of Chelidonium majus From the Viewpoint of Today's Pharmacology
Published in
Frontiers in Pharmacology, April 2018
DOI 10.3389/fphar.2018.00299
Pubmed ID
Authors

Sylwia Zielińska, Anna Jezierska-Domaradzka, Magdalena Wójciak-Kosior, Ireneusz Sowa, Adam Junka, Adam M. Matkowski

X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 108 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 108 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 20 19%
Student > Master 10 9%
Researcher 10 9%
Student > Doctoral Student 9 8%
Student > Ph. D. Student 8 7%
Other 13 12%
Unknown 38 35%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 14 13%
Medicine and Dentistry 12 11%
Agricultural and Biological Sciences 10 9%
Chemistry 8 7%
Biochemistry, Genetics and Molecular Biology 7 6%
Other 17 16%
Unknown 40 37%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 February 2024.
All research outputs
#7,944,899
of 25,810,956 outputs
Outputs from Frontiers in Pharmacology
#3,563
of 20,019 outputs
Outputs of similar age
#126,721
of 344,495 outputs
Outputs of similar age from Frontiers in Pharmacology
#85
of 397 outputs
Altmetric has tracked 25,810,956 research outputs across all sources so far. This one has received more attention than most of these and is in the 68th percentile.
So far Altmetric has tracked 20,019 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.4. This one has done well, scoring higher than 81% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 344,495 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 62% of its contemporaries.
We're also able to compare this research output to 397 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 77% of its contemporaries.